Symbol="GANX"
AssetType="Common Stock"
Name="Gain Therapeutics Inc"
Description="Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is headquartered in Bethesda, Maryland."
CIK="1819411"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="53014000"
EBITDA="-19643152"
PERatio="None"
PEGRatio="None"
BookValue="1.252"
DividendPerShare="0"
DividendYield="0"
EPS="-1.62"
RevenuePerShareTTM="0.013"
ProfitMargin="0"
OperatingMarginTTM="-131.21"
ReturnOnAssetsTTM="-0.418"
ReturnOnEquityTTM="-0.829"
RevenueTTM="150280"
GrossProfitTTM="-7660886"
DilutedEPSTTM="-1.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.47"
AnalystTargetPrice="9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="210.97"
PriceToBookRatio="1.636"
EVToRevenue="85.18"
EVToEBITDA="-0.954"
Beta="0.355"
num_52WeekHigh="6.19"
num_52WeekLow="2.8"
num_50DayMovingAverage="4.728"
num_200DayMovingAverage="4.064"
SharesOutstanding="12328800"
DividendDate="None"
ExDividendDate="None"
symbol="GANX"
open="4.37"
high="4.49"
low="4.30"
price="4.30"
volume="19908.00"
latest_trading_day="2023-07-21"
previous_close="4.40"
change="-0.10"
change_percent="-2.2727%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="20"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="80"
Volume_recent_avg="67174"
Change_recent_avg="-0.01"
Delta_recent_avg="0.28"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="80"
Aroon_momentum_negative="20"
image_negative_thumbnail_id_1="115"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0061.jpeg"
image_negative_thumbnail_id_2="518"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="1015"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_positive_thumbnail_id_2="641"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
